Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial von Motzer, Robert J, Rini, Brian I, McDermott, David F, Redman, Bruce G, Kuzel, Timothy M, Harrison, Michael R, Vaishampayan, Ulka N, Drabkin, Harry A, George, Saby, Logan, Theodore F, Margolin, Kim A, Plimack, Elizabeth R, Lambert, Alexandre M, Waxman, Ian M, Hammers, Hans J

Volltext

Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials von Marcath, Lauren A, Coe, Taylor D, Hoylman, Emily K, Redman, Bruce G, Hertz, Daniel L

Volltext

Phase 2 study of RO4929097, a gamma‐secretase inhibitor, in metastatic melanoma: SWOG 0933 von Lee, Sylvia M., Moon, James, Redman, Bruce G., Chidiac, Tarek, Flaherty, Lawrence E., Zha, Yuanyuan, Othus, Megan, Ribas, Antoni, Sondak, Vernon K., Gajewski, Thomas F., Margolin, Kim A.

Volltext

Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Ca... von MOTZER, Robert J, MICHAELSON, M. Dror, LI, Jim Z, BELLO, Carlo L, THEUER, Charles P, GEORGE, Daniel J, RINI, Brian I, REDMAN, Bruce G, HUDES, Gary R, WILDING, George, FIGLIN, Robert A, GINSBERG, Michelle S, KIM, Sindy T, BAUM, Charles M, DEPRIMO, Samuel E

Volltext

Phase I Study of Recombinant Interleukin-21 in Patients With Metastatic Melanoma and Renal Cell Carcinoma von THOMPSON, John A, CURTI, Brendan D, REDMAN, Bruce G, BHATIA, Shailender, WEBER, Jeffrey S, AGARWALA, Sanjiv S, SIEVERS, Eric L, HUGHES, Steven D, DEVRIES, Todd A, HAUSMAN, Diana F

Volltext

Adjuvant High-Dose Bolus Interleukin-2 for Patients With High-Risk Renal Cell Carcinoma: A Cytokine Working Group Randomized Trial von CLARK, Joseph I, ATKINS, Michael B, WEISS, Geoffrey R, REDMAN, Bruce G, TRETTER, Christopher P. G, MCDERMOTT, David, SMITH, John W, GORDON, Michael S, MARGOLIN, Kim A, URBA, Walter J, CREECH, Steven, FIGLIN, Robert A, DUTCHER, Janice P, FLAHERTY, Larry, SOSMAN, Jeffrey A, LOGAN, Theodore F, WHITE, Richard

Volltext

Dorsal Muscle Attenuation May Predict Failure to Respond to Interleukin-2 Therapy in Metastatic Renal Cell Carcinoma von Otemuyiwa, Bamidele, BS, Derstine, Brian A., MS, Zhang, Peng, PhD, Wong, Sandra L., MD, MS, Sabel, Michael S., MD, Redman, Bruce G., DO, Wang, Stewart C., MD, PhD, Alva, Ajjai S., MD, Davenport, Matthew S., MD

Volltext

Phase II Trial of Tetrathiomolybdate in Patients with Advanced Kidney Cancer von Redman, Bruce G, Esper, Peg, Pan, Quintin, Dunn, Rodney L, Hussain, Hero K, Chenevert, Thomas, Brewer, George J, Merajver, Sofia D

Volltext

A Phase I Trial of Tumor Lysate-pulsed Dendritic Cells in the Treatment of Advanced Cancer von CHANG, Alfred E, REDMAN, Bruce G, WHITFIELD, Joel R, NICKOLOFF, Brian J, BRAUN, Thomas M, LEE, Peter P, GEIGER, James D, MULE, James J

Volltext

Adjuvant Immunotherapy of Resected, Intermediate-Thickness, Node-Negative Melanoma With an Allogeneic Tumor Vaccine: Overall Results of a Randomized Trial of the Southwest Oncology... von SONDAK, Vernon K, LIU, P.-Y, NOYES, R. Dirk, FLAHERTY, Lawrence E, TUTHILL, Ralph J, KEMPF, Raymond A, UNGER, Joseph M, SOSMAN, Jeffrey A, THOMPSON, John A, WEISS, Geoffrey R, REDMAN, Bruce G, JAKOWATZ, James G

Volltext

Sunitinib in Patients With Metastatic Renal Cell Carcinoma von Motzer, Robert J, Rini, Brian I, Bukowski, Ronald M, Curti, Brendan D, George, Daniel J, Hudes, Gary R, Redman, Bruce G, Margolin, Kim A, Merchan, Jaime R, Wilding, George, Ginsberg, Michelle S, Bacik, Jennifer, Kim, Sindy T, Baum, Charles M, Michaelson, M. Dror

Volltext

Phase II Trial of Autologous Tumor Vaccination, Anti-CD3-Activated Vaccine-Primed Lymphocytes, and Interleukin-2 in Stage IV Renal Cell Cancer von Chang, Alfred E, Li, Qiao, Jiang, Guihua, Sayre, Donna M, Braun, Thomas M, Redman, Bruce G

Volltext

Southwest Oncology Group S0008: a phase III trial of high-dose interferon Alfa-2b versus cisplatin, vinblastine, and dacarbazine, plus interleukin-2 and interferon in patients with... von Flaherty, Lawrence E, Othus, Megan, Atkins, Michael B, Tuthill, Ralph J, Thompson, John A, Vetto, John T, Haluska, Frank G, Pappo, Alberto S, Sosman, Jeffrey A, Redman, Bruce G, Moon, James, Ribas, Antoni, Kirkwood, John M, Sondak, Vernon K

Volltext

Phase I Trials of Anti-ENPP3 Antibody-Drug Conjugates in Advanced Refractory Renal Cell Carcinomas von Thompson, John A, Motzer, Robert J, Molina, Ana M, Choueiri, Toni K, Heath, Elisabeth I, Redman, Bruce G, Sangha, Randeep S, Ernst, D Scott, Pili, Roberto, Kim, Stella K, Reyno, Leonard, Wiseman, Aya, Trave, Fabio, Anand, Banmeet, Morrison, Karen, Doñate, Fernando, Kollmannsberger, Christian K

Volltext

Concurrent whole brain radiotherapy and bortezomib for brain metastasis von Lao, Christopher D, Friedman, Judah, Tsien, Christina I, Normolle, Daniel P, Chapman, Christopher, Cao, Yue, Lee, Oliver, Schipper, Matt, Van Poznak, Catherine, Hamstra, Daniel, Lawrence, Theodore, Hayman, James, Redman, Bruce G

Volltext

A Phase 2 Trial of Complete Resection for Stage IV Melanoma: Results of Southwest Oncology Group Clinical Trial S9430 von SOSMAN, Jeffrey A, MOON, James, TUTHILL, Ralph J, WARNEKE, James A, VETTO, John T, REDMAN, Bruce G, LIU, P. Y, UNGER, Joseph M, FLAHERTY, Lawrence E, SONDAK, Vernon K

Volltext

The impact of BRAF mutation status on clinical outcomes with anti‐PD‐1 monotherapy versus combination ipilimumab/nivolumab in treatment‐naïve advanced stage melanoma von Ma, Vincent T., Daignault‐Newton, Stephanie, Waninger, Jessica J., Journey, Sara, Chopra, Zoey, Tezel, Alangoya, Redman, Bruce G., Fecher, Leslie A., Green, Michael D., Alva, Ajjai S., Lao, Christopher D.

Volltext

A phase II trial of oral diethylstilbesterol as a second-line hormonal agent in advanced prostate cancer von Smith, David C, Redman, Bruce G, Flaherty, Lawrence E, LI, Lang, Strawderman, Myla, Pienta, Kenneth J

Volltext

A phase 2 trial of complete resection for stage IV melanoma von Sosman, Jeffrey A., Moon, James, Tuthill, Ralph J., Warneke, James A., Vetto, John T., Redman, Bruce G., Liu, P. Y., Unger, Joseph M., Flaherty, Lawrence E., Sondak, Vernon K.

Volltext

A phase 2, multicenter, open‐label study of sepantronium bromide (YM155) plus docetaxel in patients with stage III (unresectable) or stage IV melanoma von Kudchadkar, Ragini, Ernst, Scott, Chmielowski, Bartosz, Redman, Bruce G., Steinberg, Joyce, Keating, Anne, Jie, Fei, Chen, Caroline, Gonzalez, Rene, Weber, Jeffrey

Volltext